====== Why, when I receive funding from the University of Strasbourg or Inserm, do I have to follow CNRS purchasing procedures? ====== ===== Because of the single management delegation! ===== ==== What is the single management delegation? ==== The single management delegation, also known as single management mandate, is a management model implemented in our institute since 1st January 2021. With this model, Inserm and the University of Strasbourg entrust CNRS with the management of their funding. In other words, **the funding made available to the IGBMC by the 3 governing bodies (CNRS, Inserm, University of Strasbourg) is held in a single cash drawer, that of the CNRS**. The CERBM GIE continues to manage research contracts (e.g. ANR, ARC etc.) ==== What types of funding fall within the scope of the single management delegation? ==== === The general rule is as follows: === * Funding that Inserm entrusts the management to the CNRS are state subsidy (1.125 M€ per year), ATIP-Avenir research contracts, INCA research contracts for which an IGBMC researcher is coordinator. * Funding that the University of Strasbourg entrusts the management to the CNRS are state subsidy (approximately 230 K€ per year), certain IdEx research contracts (Attractivité, Recherche exploratoire, Chercheurs post-doctoraux), the allocation for organisation of a thesis or HDR jury. === Although these funds are allocated by Inserm or the University, since they are in the CNRS cash drawer, CNRS purchasing procedures apply. === **There are a few exceptions to this general rule:** * all USIAS funding. These are still managed by the University of Strasbourg, * ERC research contracts. Payroll is managed by the researcher's employer. Operating expenses and internal services are managed by CERBM GIE, * INCA research contracts for which an IGBMC researcher is a partner. These are managed by the CERBM GIE. ==== What is the reason for this single management delegation? ==== The aim is to cut management costs, **reduce the time spent on staff training** in the various Inserm and University softwares for our purchasing and finance services, and **cope with staff departures that have not been replaced (e.g. 2 fewer staff in the finance service since 2020, and 3 fewer staff in the purchasing service since 2019, 2 of whom have been replaced with short-term contracts)**. ==== What does the single management delegation change compared to the previous management model? ==== === What changes for the better: === **Roughly speaking, we can say that, for the IGBMC's purchasing and finance services, the administrative layer cake is split by 2.** Before, 4 organizations managed our funding (CNRS, Inserm, University, CERBM GIE). With the delegation, there are only 2 managing bodies left (CNRS and CERBM GIE). This means that, before, where there were 4 sets of regulations, procedures, contracts and software to master, there are now only 2. **What single management delegation does not solve:** * There are still 2 management bodies, which means that certain tasks are duplicated. * Funding outside the scope of the delegation (e.g. USIAS) requires additional specific processing workflow. * Supplier prices may differ depending on whether the product is purchased by the CERBM GIE (private market) or by the CNRS (public market), leading to complications when ordering and invoicing. ==== Why was CNRS chosen as delegate? ==== CNRS is the most advanced in terms of accounting automation, and the only one capable of absorbing the surplus of invoices (those previously processed by Inserm and the University). ==== What about the IGBMC's other support services? ==== **In terms of financial resources, there are now only 2 management bodies, but in terms of human resources 4 employers are still present**. The single management delegation does not therefore affect the HR nor the Missions services, which continue to deal with the 4 employers and with their own regulations and softwares.